Grifols Australia PTY Ltd

Grifols Australia was established in 1990. Based in Melbourne, we cover the Australian and New Zealand markets. Our state-of-the art of Blood Typing reagents manufacturing facility is also based in our site in Melbourne.

We offer a comprehensive portfolio of Grifols products and. Safety and quality are our top priorities as we deliver on our mission to improve the health and well-being of people around the world.

Grifols Australia

Unit 5 / 80 Fairbank Road
Clayton South
Victoria  3169
AUSTRALIA

Contact information:
Tel: +61 3 95359333
Fax: +61 3 95359300
Mail:
australia_info@grifols.com
australia_medinfo@grifols.com

 

Notification of adverse reactions
To report an adverse drug reaction click here 

See on Google Maps

Contact with Grifols

Corp Contact Us EN ES

All fields are required unless otherwise stated

0 characters left

Data protection information
Data controller: The Grifols’ group company to which you submit the request. Purpose: To manage your requests of information, suggestions and/or queries. Legal basis: Legitimate interest. Recipients: Grifols’ group companies, Other third parties. Rights: To access, rectify and erase personal data, as well as other rights detailed in the additional information section. Additional information: For additional information on personal data protection check here.

 

By clicking the button below, I declare being informed that my data is being used as described in the data protection information.

Certificate and ISO policy

Grifols Australia Pty Ltd is a member of the Grifols global family of companies, founded in 1909 by Josep Antoni Grifols i Lucas. Grifols is a leader in plasma collection and a leading provider of plasma-derived medicines and other innovative biopharmaceuticals. Grifols Australia offers a comprehensive range of transfusion medicine, immunoassay and pharmacy validation solutions for clinical laboratories, blood banks and hospitals. Grifols Australia maintains ISO 9001:2008 certification and is licensed by the Therapeutic Goods Administration to develop, manufacture, and distribute in-vitro diagnostic products. Grifols Australia is committed to quality, safety, and innovation to meet the demands of patient safety as well as represent the pioneering spirit of the global organization.